TORONTO, ONTARIO -- (MARKET WIRE) -- 03/19/07 -- Innovium Capital Corp. ("Innovium") (TSX VENTURE: IN)(FRANKFURT: IH7) reports that its shares have been listed for trading on the Frankfurt Stock Exchange ("Frankfurt"), effective the start of trading today. Innovium's trading symbol on Frankfurt is IH7; its ISIN (International Stock Identification Number) is CA45768W1068; and its WKN (German Security Code) is A0CAJ8. It is hoped that the Frankfurt listing will facilitate better access to international capital markets and will assist in fueling Innovium's future growth.

Innovium invests in innovative opportunities and benefits from an ongoing income stream from past agri-divestitures. Its venture investment portfolio is focused upon Seed Media Group, LLC, an emerging science media and communications company that develops original science content, including www.scienceblogs.com. The rapid growth of the digital media "space" is providing lucrative opportunities. This coupled with Innovium's constructive relationship with Seed Media Group will likely become an area of increased investment concentration.

Other investments include CablesEdge Software, which has developed Voice on the Go, the simplest, and most accessible, way for mobile users to access desktop information with the fewest keyclicks from any mobile device; First Person Plural, an interactive marketing and advergaming company; and RxRite, a developer of point-of-care e-Prescribing solutions providing physicians, pharmacies, payers and Pharmacy Benefit Managers with the ability to communicate effectively for the safe and secure creation, transmission, and processing of electronic prescriptions.

Innovium Capital trades under the symbol IN on the TSX Venture Exchange and IH7 on the Frankfurt Stock Exchange.

For additional information contact: info@innovium.ca.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. We seek safe harbour.

Contacts:
Innovium Capital Corp.
Neil Raymond
Chairman and CEO
(514) 281-0481
(514) 281-0294 (FAX)
Email: ceo@innovium.ca

Innovium Capital Corp.
Jamie Macintosh
President and COO
(416) 862-7444
(416) 862-7007 (FAX)
Email: president@innovium.ca

Innovium Capital Corp.
Julio DiGirolamo
CFO and Corporate Secretary
(416) 862-7444
(416) 862-7007 (FAX)
Email: cfo@innovium.ca